This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
public health | 614 |
infectious diseases | 193 |
health care | 173 |
european countries | 169 |
climate change | 162 |
hemorrhagic fever | 153 |
world war | 145 |
raccoon dogs | 142 |
united states | 135 |
raccoon dog | 121 |
job satisfaction | 117 |
working conditions | 114 |
west nile | 111 |
avian influenza | 107 |
influenza virus | 100 |
borne encephalitis | 99 |
risk factors | 96 |
per cent | 96 |
fever virus | 90 |
learning objectives | 88 |
health promotion | 87 |
infectious disease | 85 |
congo hemorrhagic | 81 |
developing countries | 80 |
nile virus | 78 |
encephalitis virus | 72 |
spotted fever | 72 |
natural foci | 71 |
th century | 70 |
acute respiratory | 67 |
differential diagnosis | 66 |
closely related | 63 |
european union | 63 |
may also | 62 |
respiratory syndrome | 62 |
north america | 61 |
virus infection | 61 |
across europe | 61 |
middle east | 60 |
risk perception | 59 |
communicable diseases | 57 |
important role | 57 |
imaging techniques | 57 |
pandemic influenza | 56 |
cord uid | 56 |
yersinia pestis | 56 |
doc id | 56 |
imaging modalities | 55 |
northern eurasia | 53 |
economic growth | 53 |
become familiar | 51 |
severe acute | 51 |
influenza viruses | 49 |
far east | 49 |
phylogenetic analysis | 48 |
clinical practice | 47 |
energy transitions | 47 |
new public | 47 |
perceived threat | 46 |
member states | 46 |
amino acid | 46 |
presentation will | 46 |
strains isolated | 46 |
central europe | 46 |
world health | 45 |
black death | 45 |
virus strains | 45 |
copyright holder | 44 |
mr imaging | 44 |
health systems | 44 |
mediterranean spotted | 44 |
pet ct | 44 |
czech republic | 44 |
health services | 43 |
nyctereutes procyonoides | 43 |
small airports | 43 |
recent years | 43 |
incubation period | 43 |
arthropod vectors | 42 |
eastern europe | 42 |
hong kong | 42 |
disease control | 42 |
magnetic resonance | 42 |
emerging infectious | 41 |
author funder | 41 |
second world | 41 |
version posted | 41 |
granted medrxiv | 41 |
wild birds | 41 |
imaging findings | 40 |
chikungunya virus | 40 |
european research | 40 |
many countries | 40 |
virus infections | 40 |
wide range | 40 |
united kingdom | 40 |
influenza pandemic | 39 |
infection rate | 39 |
northern europe | 39 |
health literacy | 39 |
vertebrate hosts | 39 |
yellow fever | 39 |
first world | 38 |
risk factor | 38 |
antibiotic resistance | 38 |
borne diseases | 38 |
african countries | 37 |
clinical features | 37 |
east asia | 37 |
japanese encephalitis | 37 |
made available | 36 |
twentieth century | 36 |
european commission | 36 |
small indian | 36 |
breast cancer | 35 |
clinical trials | 35 |
dengue virus | 35 |
ticks collected | 35 |
war ii | 35 |
computed tomography | 34 |
social distancing | 34 |
primary care | 34 |
exchange rate | 34 |
international license | 34 |
developed countries | 34 |
large number | 34 |
radiation dose | 34 |
ep adoption | 33 |
western siberia | 33 |
widely used | 33 |
years ago | 33 |
astrakhan region | 33 |
domestic animals | 33 |
nervous system | 33 |
medical care | 32 |
borne viruses | 32 |
porcine epidemic | 32 |
will also | 32 |
per year | 32 |
soft tissue | 32 |
research policy | 31 |
human rights | 31 |
southern europe | 31 |
dog nyctereutes | 31 |
imported cases | 31 |
see chapter | 31 |
lung cancer | 30 |
infection control | 30 |
indian mongoose | 30 |
health status | 30 |
respiratory tract | 30 |
posted may | 30 |
general equilibrium | 30 |
international catalogue | 30 |
highly pathogenic | 30 |
health organization | 30 |
wage inequality | 29 |
new york | 29 |
central asia | 29 |
egyptian mongoose | 29 |
rickettsia conorii | 29 |
supply chain | 29 |
sectional imaging | 28 |
health system | 28 |
western europe | 28 |
risk perceptions | 28 |
interventional radiology | 28 |
primorsky krai | 28 |
different countries | 28 |
clinical symptoms | 28 |
south africa | 28 |
imaging modality | 28 |
heart disease | 28 |
medical imaging | 28 |
pidd patients | 28 |
nineteenth century | 27 |
novel coronavirus | 27 |
saharan africa | 27 |
caspian sea | 27 |
control measures | 27 |
first century | 27 |
health issues | 27 |
emergency powers | 27 |
genome sequence | 27 |
endemic areas | 26 |
nucleocapsid protein | 26 |
causative agent | 26 |
antimicrobial resistance | 26 |
patient care | 26 |
severe disease | 26 |
air transport | 26 |
image quality | 26 |
national health | 26 |
tahyna virus | 26 |
diagnostic imaging | 26 |
weighted imaging | 26 |
volga delta | 26 |
imaging technique | 26 |
european bats | 26 |
experimental infection | 26 |
imaging biomarkers | 26 |
spanish flu | 25 |
infectious agents | 25 |
haemorrhagic fever | 25 |
strain leiv | 25 |
war i | 25 |
common genet | 25 |
human disease | 25 |
will discuss | 25 |
emerging infections | 25 |
clinical isolates | 25 |
resistance genes | 25 |
mortality rate | 25 |
roma children | 25 |
european bat | 25 |
intensive care | 25 |
new cases | 25 |
zika virus | 24 |
central nervous | 24 |
resonance imaging | 24 |
last years | 24 |
viruses isolated | 24 |
care systems | 24 |
viral infections | 24 |
polyprotein precursor | 24 |
viral infection | 24 |
following flooding | 24 |
south korea | 24 |
tourism sector | 24 |
sandfly fever | 24 |
clostridium difficile | 24 |
communicable disease | 24 |
world wars | 24 |
may occur | 24 |
functional imaging | 24 |
total number | 23 |
primary immunodeficiency | 23 |
latin america | 23 |
tumour response | 23 |
ancient pathogen | 23 |
epidemic diarrhea | 23 |
high levels | 23 |
human cases | 23 |
central european | 23 |
soviet union | 23 |
high risk | 23 |
supply chains | 23 |
molecular imaging | 23 |
lecture will | 23 |
million people | 23 |
institutional context | 23 |
asian countries | 23 |
will review | 23 |
coronavirus disease | 23 |
new virus | 23 |
disease prevention | 22 |
session will | 22 |
mortality rates | 22 |
incidental findings | 22 |
health insurance | 22 |
red fox | 22 |
syndrome coronavirus | 22 |
disease outbreaks | 22 |
renal syndrome | 22 |
ce serocomplex | 22 |
social media | 22 |
ixodidae ticks | 22 |
see table | 22 |
nile fever | 22 |
sars cov | 22 |
bubonic plague | 22 |
peer review | 21 |
i will | 21 |
immune response | 21 |
genetic characterization | 21 |
mental health | 21 |
community health | 21 |
across countries | 21 |
dt framework | 21 |
within europe | 21 |
cardiovascular disease | 21 |
human infection | 21 |
international trade | 21 |
practice types | 21 |
international committee | 21 |
case fatality | 21 |
new coronavirus | 21 |
recent studies | 21 |
chikungunya fever | 21 |
time pcr | 21 |
rift valley | 20 |
countries according | 20 |
ixodes ricinus | 20 |
dynamic contrast | 20 |
european part | 20 |
sociotechnical systems | 20 |
high level | 20 |
south america | 20 |
tract infection | 20 |
significant differences | 20 |
higher risk | 20 |
age groups | 20 |
valley fever | 20 |
dengue fever | 20 |
data set | 20 |
bhanja virus | 20 |
ancient dna | 20 |
virus isolation | 20 |
age group | 20 |
immunocompromised patients | 20 |
first time | 20 |
higher rates | 20 |
hiv aids | 20 |
fatality rate | 20 |
blood flow | 20 |
genetic diversity | 19 |
imaging plays | 19 |
target areas | 19 |
new world | 19 |
risk groups | 19 |
systematic review | 19 |
diagnostic tests | 19 |
global health | 19 |
population health | 19 |
imaging methods | 19 |
two months | 19 |
industrialized countries | 19 |
performed using | 19 |
southeastern asia | 19 |
may lead | 19 |
many cases | 19 |
positive results | 19 |
increased risk | 19 |
eu research | 19 |
clinical audit | 19 |
tumour size | 19 |
confirmed cases | 19 |
contrast agents | 19 |
two strains | 19 |
surveillance systems | 19 |
virus taxonomy | 19 |
great powers | 19 |
key role | 19 |
coronary artery | 18 |
nairovirus genus | 18 |
staphylococcus aureus | 18 |
different imaging | 18 |
family bunyaviridae | 18 |
chain reaction | 18 |
living conditions | 18 |
general population | 18 |
aedes aegypti | 18 |
bat species | 18 |
minimally invasive | 18 |
air cargo | 18 |
united nations | 18 |
demand pressures | 18 |
cardiovascular diseases | 18 |
first case | 18 |
high prevalence | 18 |
income countries | 18 |
aedes albopictus | 18 |
research area | 18 |
general public | 18 |
two main | 18 |
human body | 18 |
serocomplex viruses | 18 |
former soviet | 18 |
case study | 18 |
sri lanka | 18 |
last decade | 18 |
deep transition | 17 |
russian plain | 17 |
southeast asia | 17 |
gold standard | 17 |
igm antibodies | 17 |
toscana virus | 17 |
southern finland | 17 |
clinical picture | 17 |
chronic diseases | 17 |
health policy | 17 |
virus isolated | 17 |
rickettsia sibirica | 17 |
uukuniemi virus | 17 |
endovascular treatment | 17 |
natural history | 17 |
health interventions | 17 |
hantavirus infections | 17 |
air transportation | 17 |
international order | 17 |
even though | 17 |
clinical applications | 17 |
eu countries | 17 |
complete genome | 17 |
host population | 17 |
health protection | 17 |
many different | 17 |
nuclear medicine | 17 |
lower rates | 17 |
long time | 17 |
small bowel | 17 |
mediterranean basin | 17 |
present study | 17 |
data collection | 17 |
among roma | 17 |
health problems | 17 |
uukuniemi group | 17 |
home order | 16 |
drug resistance | 16 |
east asian | 16 |
years old | 16 |
care providers | 16 |
innovation policy | 16 |
air pollution | 16 |
hiv infection | 16 |
early detection | 16 |
polymerase chain | 16 |
cent among | 16 |
disease transmission | 16 |
whole body | 16 |
treatment response | 16 |
one hand | 16 |
sequence analysis | 16 |
significantly higher | 16 |
russian federation | 16 |
health measures | 16 |
cold war | 16 |
rabies virus | 16 |
rickettsial diseases | 16 |
among countries | 16 |
lyme disease | 16 |
many european | 16 |
ordering agent | 16 |
central role | 16 |
perfusion imaging | 16 |
human resources | 16 |
southern part | 16 |
countries within | 16 |
icu admission | 16 |
physical environment | 16 |
omsk hemorrhagic | 16 |
body composition | 16 |
lung disease | 16 |
respiratory viruses | 16 |
literature review | 16 |
efficacy beliefs | 16 |
northern italy | 16 |
skull base | 16 |
statistically significant | 16 |
clinical presentation | 16 |
cut flower | 16 |
european region | 16 |
chronic disease | 16 |
nipah virus | 16 |
infected individuals | 16 |
atmospheric circulation | 16 |
mediterranean countries | 15 |
cystic lesions | 15 |
among others | 15 |
exchange rates | 15 |
thermal ablation | 15 |
genetic analysis | 15 |
prostate cancer | 15 |
emerging viruses | 15 |
cruise passengers | 15 |
human infections | 15 |
common cold | 15 |
geographical distribution | 15 |
global warming | 15 |
public policy | 15 |
trade flows | 15 |
economic development | 15 |
environmental impact | 15 |
mg kg | 15 |
tickborne encephalitis | 15 |
international health | 15 |
financial crisis | 15 |
interest rates | 15 |
molecular biology | 15 |
three segments | 15 |
eastern siberia | 15 |
biofilm formation | 15 |
fatality rates | 15 |
getah virus | 15 |
lymph nodes | 15 |
segment encodes | 15 |
virus circulation | 15 |
genetic variation | 15 |
financial capital | 15 |
ivanovsky institute | 15 |
bunyaviridae family | 15 |
klebsiella pneumoniae | 15 |
diagnostic accuracy | 15 |
bone marrow | 15 |
free trade | 15 |
labor market | 15 |
will continue | 15 |
accurate diagnosis | 15 |
immune system | 15 |
long run | 15 |
stem cell | 15 |
bronze age | 15 |
short run | 15 |
high mortality | 15 |
european level | 15 |
north african | 15 |
people living | 15 |
may result | 15 |
ct angiography | 15 |
will focus | 15 |
specific antibodies | 15 |
sporadic cases | 15 |
several studies | 15 |
international politics | 15 |
social environment | 15 |
risk assessment | 15 |
total war | 15 |
real time | 15 |
clinical medicine | 15 |
medrxiv preprint | 15 |
animal health | 15 |
sustainable development | 15 |
disease surveillance | 15 |
world economy | 15 |
antibiotic treatment | 14 |
second half | 14 |
among children | 14 |
stool samples | 14 |
aedes mosquitoes | 14 |
economic activity | 14 |
response efficacy | 14 |
lymph node | 14 |
hyalomma marginatum | 14 |
less likely | 14 |
physical capital | 14 |
genome sequences | 14 |
diarrhea virus | 14 |
bone tumours | 14 |
broad range | 14 |
heavy rainfall | 14 |
environmental factors | 14 |
liver metastases | 14 |
species identification | 14 |
originally isolated | 14 |
countries inequality | 14 |
rna viruses | 14 |
will increase | 14 |
clinical signs | 14 |
across european | 14 |
respiratory disease | 14 |
uriae ticks | 14 |
extreme weather | 14 |
febrile illness | 14 |
african country | 14 |
clinical microbiology | 14 |
clinical samples | 14 |
wide variety | 14 |
region transmission | 14 |
north atlantic | 14 |
pcr testing | 14 |
pregnant women | 14 |
cubed model | 14 |
clinically relevant | 14 |
structural proteins | 14 |
wild animals | 14 |
data sets | 14 |
radiation protection | 14 |
economic impact | 14 |
ep engagement | 14 |
sexually transmitted | 14 |
fluid collections | 14 |
treatment options | 14 |
molecular characterization | 14 |
breast imaging | 14 |
times higher | 14 |
escherichia coli | 14 |
natural reservoir | 14 |
nucleic acid | 14 |
early diagnosis | 14 |
reservoir hosts | 14 |
capital flows | 14 |
global approach | 14 |
contrast enhancement | 14 |
resistant strains | 14 |
mosquitoes collected | 14 |
north american | 14 |
also known | 14 |
contrast media | 14 |
prototypical strain | 14 |
cardiac ct | 14 |
great power | 13 |
throughout europe | 13 |
whole genome | 13 |
take place | 13 |
medical treatment | 13 |
pathogenic avian | 13 |
second wave | 13 |
case report | 13 |
preventive measures | 13 |
new zealand | 13 |
quality control | 13 |
will help | 13 |
pandemic disease | 13 |
high degree | 13 |
may help | 13 |
analysis based | 13 |
cases per | 13 |
lassa fever | 13 |
high latitudes | 13 |
risk premia | 13 |
best practices | 13 |
also found | 13 |
eu member | 13 |
one strain | 13 |
mechanical ventilation | 13 |
close proximity | 13 |
disease spread | 13 |
cruise companies | 13 |
respiratory diseases | 13 |
reference case | 13 |
health education | 13 |
also important | 13 |
bat lyssavirus | 13 |
spatial resolution | 13 |
will provide | 13 |
took place | 13 |
council regulation | 13 |
different regions | 13 |
may cause | 13 |
swine influenza | 13 |
demographic change | 13 |
european science | 13 |
st century | 13 |
indian grey | 13 |
adverse events | 13 |
drinking water | 13 |
significantly associated | 13 |
genome analysis | 13 |
resource allocation | 13 |
neonatal pigs | 13 |
brain tumours | 13 |
powassan virus | 13 |
genus nairovirus | 13 |
virus isolates | 13 |
water supply | 13 |
direct contact | 13 |
borne phleboviruses | 13 |
growth rates | 13 |
authors declare | 13 |
puumala virus | 13 |
young children | 13 |
border closures | 13 |
cohort study | 13 |
vast majority | 13 |
radiofrequency ablation | 13 |
results show | 13 |
work intensity | 13 |
clinical information | 13 |
multiple sociotechnical | 13 |
human beings | 13 |
susceptibility testing | 13 |
case studies | 13 |
increasingly used | 13 |
multidisciplinary team | 13 |
two different | 13 |
arboviral zoonoses | 13 |
may provide | 13 |
global economy | 13 |
patient management | 13 |
river delta | 13 |
coronary cta | 13 |
years later | 13 |
cases imported | 13 |
per capita | 13 |
arboviral infections | 12 |
cancer screening | 12 |
response criteria | 12 |
virus group | 12 |
health needs | 12 |
within countries | 12 |
diseases following | 12 |
cruise ship | 12 |
rotator cuff | 12 |
cervical cancer | 12 |
california encephalitis | 12 |
balamuthia mandrillaris | 12 |
epidemic outbreaks | 12 |
molecular epidemiology | 12 |
blood pressure | 12 |
glycoproteins gn | 12 |
study period | 12 |
population groups | 12 |
perceived severity | 12 |
different types | 12 |
near future | 12 |
satisfaction across | 12 |
ordering agents | 12 |
transplant recipients | 12 |
lwa index | 12 |
future research | 12 |
invasive species | 12 |
care services | 12 |
temperate zone | 12 |
best practice | 12 |
northern part | 12 |
antigen detection | 12 |
disease incidence | 12 |
ricinus ticks | 12 |
population density | 12 |
pet imaging | 12 |
relatively high | 12 |
human population | 12 |
six months | 12 |
infected patients | 12 |
case load | 12 |
low levels | 12 |
will need | 12 |
special attention | 12 |
differences among | 12 |
immune compromised | 12 |
two groups | 12 |
echinococcus multilocularis | 12 |
also present | 12 |
flower industry | 12 |
vulpes vulpes | 12 |
eastern slovakia | 12 |
resistance mechanisms | 12 |
health authorities | 12 |
national level | 12 |
new arbovirus | 12 |
many years | 12 |
primary prevention | 12 |
human history | 12 |
saudi arabia | 12 |
real exchange | 12 |
horizon europe | 12 |
climate policy | 12 |
new technologies | 12 |
ninth report | 12 |
drug resistant | 12 |
tap water | 12 |
among non | 12 |
acute phase | 12 |
hemorrhagic fevers | 12 |
pathogen dna | 12 |
year old | 12 |
reduced susceptibility | 12 |
health professionals | 12 |
seasonal influenza | 12 |
commonly used | 12 |
development goals | 12 |
cc isolates | 12 |
higher levels | 12 |
state collection | 12 |
creative commons | 12 |
productivity growth | 12 |
young people | 12 |
important factor | 12 |
khabarovsk krai | 12 |
pathogen genomes | 12 |
population growth | 12 |
case reports | 12 |
environmental management | 12 |
crude oil | 12 |
acid sequence | 12 |
infected people | 12 |
policy makers | 12 |
western part | 12 |
economic crisis | 12 |
social networks | 12 |
asylum seekers | 12 |
myocardial infarction | 12 |
great britain | 12 |
envelope glycoproteins | 12 |
determine whether | 11 |
relatively low | 11 |
crucial role | 11 |
least one | 11 |
radiation therapy | 11 |
including certain | 11 |
southern taiga | 11 |
flu pandemic | 11 |
avian flu | 11 |
sea level | 11 |
antimicrobial therapy | 11 |
case finding | 11 |
loss rate | 11 |
antigenic relationships | 11 |
new challenges | 11 |
well established | 11 |
technological development | 11 |
healthy cities | 11 |
common cause | 11 |
border controls | 11 |
ct perfusion | 11 |
frequently used | 11 |
additional information | 11 |
sindbis virus | 11 |
among humans | 11 |
health concern | 11 |
year period | 11 |
us dollar | 11 |
immunocompromised hosts | 11 |
diagnostic workup | 11 |
health law | 11 |
acute stroke | 11 |
north africa | 11 |
spect ct | 11 |
air travel | 11 |
epidemiological studies | 11 |
european regions | 11 |
contrast agent | 11 |
monoclonal antibodies | 11 |
weighted images | 11 |
end points | 11 |
southern france | 11 |
routine data | 11 |
others viruses | 11 |
positive phase | 11 |
radiation exposure | 11 |
several years | 11 |
borne disease | 11 |
ottawa charter | 11 |
clean water | 11 |
volga river | 11 |
kul virus | 11 |
high number | 11 |
cerebral blood | 11 |
special focus | 11 |
etiologically linked | 11 |
conorii subsp | 11 |
become infected | 11 |
green buildings | 11 |
equilibrium model | 11 |
rickettsia slovaca | 11 |
environmental challenges | 11 |
lassa virus | 11 |
first deep | 11 |
available evidence | 11 |
four different | 11 |
russian state | 11 |
treatment planning | 11 |
landscape belts | 11 |
relapsing fever | 11 |
arboviruses including | 11 |
travel restrictions | 11 |
cleavage site | 11 |
well known | 11 |
strains belonging | 11 |
different levels | 11 |
igg antibodies | 11 |
invasive candidiasis | 11 |
former ussr | 11 |
commander islands | 11 |
mr pet | 11 |
core domain | 11 |
white matter | 11 |
cruise ships | 11 |
cerebrospinal fluid | 11 |
may explain | 11 |
european parliament | 11 |
health inequalities | 11 |
limited number | 11 |
will give | 11 |
east respiratory | 11 |
risk premium | 11 |
clinical use | 11 |
added value | 11 |
arbovirus isolated | 11 |
west africa | 11 |
mg ml | 11 |
difficile infection | 11 |
african migrants | 11 |
infections caused | 11 |
health powers | 11 |
young adults | 11 |
ct imaging | 11 |
molecular methods | 11 |
cases reported | 11 |
targeted therapies | 11 |
world bank | 11 |
environmental practices | 11 |
basic research | 11 |
million passengers | 11 |
perceived vulnerability | 11 |
contrast medium | 11 |
ixodes uriae | 11 |
reported cases | 11 |
medical conditions | 10 |
policy responses | 10 |
three strains | 10 |
spanish influenza | 10 |
functional information | 10 |
interventional procedures | 10 |
argasidae ticks | 10 |
many people | 10 |
migratory birds | 10 |
better understand | 10 |
wage loss | 10 |
common causes | 10 |
global economic | 10 |
clinical manifestations | 10 |
percentage points | 10 |
studies suggest | 10 |
mediterranean area | 10 |
surgical treatment | 10 |
tick bite | 10 |
social support | 10 |
red foxes | 10 |
viruses among | 10 |
case count | 10 |
environmental impacts | 10 |
type esbls | 10 |
interventional oncology | 10 |
durable goods | 10 |
artery disease | 10 |
specific anti | 10 |
partial functioning | 10 |
full capacity | 10 |
promote health | 10 |
northern africa | 10 |
patient dose | 10 |
russian far | 10 |
genomic data | 10 |
will cover | 10 |
quality assurance | 10 |
organ transplantation | 10 |
ionising radiation | 10 |
mrsa isolates | 10 |
focused ultrasound | 10 |
global climate | 10 |
mass spectrometry | 10 |
europe date | 10 |
bacterial meningitis | 10 |
countries will | 10 |
like gene | 10 |
infection rates | 10 |
kalmyk republic | 10 |
gastric cancer | 10 |
health practice | 10 |
fulica atra | 10 |
carbon emissions | 10 |
ebola virus | 10 |
heart failure | 10 |
zoonotic viruses | 10 |
primary health | 10 |
healthy people | 10 |
life cycle | 10 |
flu virus | 10 |
urinary tract | 10 |
influenza vaccination | 10 |
modern era | 10 |
technological advances | 10 |
blood culture | 10 |
clinical data | 10 |
putus pick | 10 |
factors affecting | 10 |
crimean hemorrhagic | 10 |
interest rate | 10 |
group viruses | 10 |
increasingly important | 10 |
monetary policy | 10 |
recent decades | 10 |
clinical history | 10 |
early stage | 10 |
low risk | 10 |
satisfaction among | 10 |
european centre | 10 |
drug users | 10 |
currently available | 10 |
sars epidemic | 10 |
candida species | 10 |
neutralizing antibodies | 10 |
major cause | 10 |
antibiotic therapy | 10 |
first isolated | 10 |
comparative vulnerability | 10 |
infection among | 10 |
home range | 10 |
two patients | 10 |
trade area | 10 |
genome sequencing | 10 |
length genome | 10 |
much higher | 10 |
many patients | 10 |
eastern part | 10 |
different species | 10 |
smaller airports | 10 |
lower respiratory | 10 |
hospital care | 10 |
health threats | 10 |
health consequences | 10 |
bone metastases | 10 |
significantly lower | 10 |
widely available | 10 |
limited resources | 10 |
surveillance system | 10 |
colorectal cancer | 10 |
heart rate | 10 |
one patient | 10 |
bacterial infections | 10 |
rna polymerase | 10 |
domestic product | 10 |
solid organ | 10 |
visited port | 10 |
natural disasters | 10 |
international cooperation | 10 |
clinical findings | 10 |
sea basin | 10 |
safe water | 10 |
three years | 10 |
national governments | 10 |
clinical specimens | 10 |
viral hemorrhagic | 10 |
resistant isolates | 10 |
imaging follow | 10 |
data suggest | 10 |
regression analysis | 10 |
gel electrophoresis | 10 |
nucleotide sequence | 10 |
inflammatory disease | 10 |
patient days | 10 |
adjustment costs | 10 |
east africa | 10 |
may indicate | 10 |
health targets | 10 |
strain isolated | 10 |
imaging may | 10 |
vertebrate host | 10 |
predictive value | 10 |
diseases among | 10 |
antibiotic use | 10 |
bartonella infection | 10 |
disease outbreak | 10 |
integral part | 10 |
cancer patients | 10 |
previous studies | 10 |
coronary ct | 10 |
plague pandemic | 10 |
war period | 10 |
independent states | 10 |
linked immunosorbent | 10 |
oral microbiology | 10 |
higher prevalence | 10 |
small mammals | 10 |
widely accepted | 10 |
mean loss | 10 |
stranded rna | 10 |
lethal outcomes | 10 |
acid sequences | 10 |
two years | 10 |
european states | 10 |
session objectives | 10 |
dermacentor marginatus | 10 |
may affect | 10 |
trade balances | 10 |
merkel cell | 9 |
international system | 9 |
high incidence | 9 |
human resource | 9 |
important information | 9 |
hearing loss | 9 |
infected mosquitoes | 9 |
health laws | 9 |
will address | 9 |
nosocomial infections | 9 |
individual countries | 9 |
risk communication | 9 |
secondary prevention | 9 |
significantly increased | 9 |
lessons learned | 9 |
economic conditions | 9 |
occupational health | 9 |
effect size | 9 |
confirmed case | 9 |
also include | 9 |
available data | 9 |
septic shock | 9 |
may even | 9 |
pk pd | 9 |
positron emission | 9 |
mycobacterium tuberculosis | 9 |
grey mongoose | 9 |
health service | 9 |
major epicentres | 9 |
response assessment | 9 |
plasmodium falciparum | 9 |
group differences | 9 |
vaccination coverage | 9 |
pcr assays | 9 |
eu states | 9 |
dogs may | 9 |
beam ct | 9 |
diagnostic methods | 9 |
evolutionary history | 9 |
myodes glareolus | 9 |
zoonotic potential | 9 |
biological properties | 9 |
imaging will | 9 |
techniques will | 9 |
pig farms | 9 |
interventional radiologists | 9 |
protection motivation | 9 |
serological methods | 9 |
liver disease | 9 |
acinetobacter baumannii | 9 |
wide spectrum | 9 |
fungal infections | 9 |
rapid detection | 9 |
immunosorbent assay | 9 |
rectal cancer | 9 |
viral loads | 9 |
marshall plan | 9 |
better understanding | 9 |
analysis showed | 9 |
blood volume | 9 |
paediatric patients | 9 |
improve health | 9 |
field gel | 9 |
densely populated | 9 |
value chains | 9 |
imaging studies | 9 |
higher mortality | 9 |
billion euros | 9 |
individual patient | 9 |
first two | 9 |
medical schools | 9 |
international society | 9 |
patient selection | 9 |
culex pipiens | 9 |
epidemic diarrhoea | 9 |
dhori virus | 9 |
high fever | 9 |
choriomeningitis virus | 9 |
healthy individuals | 9 |
western mediterranean | 9 |
capital stocks | 9 |
different european | 9 |
wage losses | 9 |
great importance | 9 |
health regulations | 9 |
large outbreak | 9 |
growth rate | 9 |
granulomatous disease | 9 |
abdominal injuries | 9 |
mic mg | 9 |
risk patients | 9 |
will likely | 9 |
diagnostic tools | 9 |
virulence factors | 9 |
reproductive number | 9 |
laboratory findings | 9 |
pivotal role | 9 |
airborne transmission | 9 |
bacterial pathogens | 9 |
international sanitary | 9 |
vice versa | 9 |
many areas | 9 |
high case | 9 |
also possible | 9 |
ec eu | 9 |
precision medicine | 9 |
negative bacteria | 9 |
factors associated | 9 |
imaging features | 9 |
argas ticks | 9 |
preparedness plans | 9 |
less common | 9 |
experimental studies | 9 |
country blocks | 9 |
disease progression | 9 |
aquatic birds | 9 |
leading role | 9 |
anas platyrhynchos | 9 |
bat rabies | 9 |
ixodidae tick | 9 |
economic consequences | 9 |
will present | 9 |
human pathology | 9 |
imaging protocols | 9 |
knowledge society | 9 |
two cases | 9 |
border control | 9 |
two countries | 9 |
new drugs | 9 |
many diseases | 9 |
skin lesions | 9 |
european integration | 9 |
inflammatory response | 9 |
ixodes persulcatus | 9 |
adverse effects | 9 |
clinical studies | 9 |
first step | 9 |
clinical diagnosis | 9 |
cases occur | 9 |
influenza pandemics | 9 |
many others | 9 |
technical aspects | 9 |
neuroendocrine tumours | 9 |
cost effective | 9 |
european airports | 9 |
existing medical | 9 |
flood events | 9 |
dry conditions | 9 |
long term | 9 |
cause disease | 9 |
two species | 9 |
land use | 9 |
technical change | 9 |
southern regions | 9 |
human genome | 9 |
migrating birds | 9 |
sars coronavirus | 9 |
electron microscopy | 9 |
mass vaccination | 9 |
airport operations | 9 |
estimated probability | 9 |
provide information | 9 |
cell lines | 9 |
modern day | 9 |
virus disease | 9 |
widely distributed | 9 |
gross domestic | 9 |
emergency radiology | 9 |
nonstructural protein | 9 |
malignant lesions | 9 |
contagious disease | 9 |
cruise brands | 9 |
arbovirus infections | 9 |
university hospital | 9 |
local recurrence | 9 |
noise reduction | 9 |
local control | 9 |
breast mri | 9 |
mri will | 9 |
average levels | 9 |
among wild | 9 |
often associated | 9 |
tyrosine kinase | 9 |
energy consumption | 9 |
national security | 9 |
weighted mri | 9 |
effect sizes | 9 |
total population | 9 |
imaging method | 9 |
takes place | 9 |
genetta genetta | 9 |
response evaluation | 9 |
inclusion criteria | 9 |
many studies | 9 |
oil transitions | 9 |
spin labelling | 9 |
family flaviviridae | 9 |
hospitalised patients | 9 |
coal industry | 9 |
breeding success | 9 |
farm animals | 9 |
dog population | 9 |
multiple myeloma | 9 |
poor countries | 9 |
preventive medicine | 9 |
higher education | 9 |
methods used | 9 |
work time | 9 |
laboratory diagnosis | 9 |
primary immunodeficiencies | 9 |
serological tests | 9 |
specific humidity | 9 |
tick bites | 9 |
common murre | 9 |
human populations | 9 |
transmission rates | 9 |
time quality | 9 |
feeder pigs | 9 |
thyroid nodules | 9 |
time period | 9 |
best imaging | 9 |
malignant tumours | 8 |
anopheles hyrcanus | 8 |
new imaging | 8 |
global air | 8 |
central asian | 8 |
ornithodoros capensis | 8 |
advocacy groups | 8 |
floriculture industry | 8 |
community action | 8 |
first described | 8 |
may present | 8 |
reverse transcription | 8 |
host cell | 8 |
cns lesions | 8 |
genotype i | 8 |
anthropogenic biocenoses | 8 |
resistance levels | 8 |
first one | 8 |
patients treated | 8 |
water supplies | 8 |
eighteenth century | 8 |
resistant tb | 8 |
smaller organisations | 8 |
structured reporting | 8 |
minority groups | 8 |
sequence typing | 8 |
emission tomography | 8 |
immunodeficiency diseases | 8 |
enhanced surveillance | 8 |
production function | 8 |
main vector | 8 |
first wave | 8 |
herpestes auropunctatus | 8 |
trade liberalization | 8 |
factors influencing | 8 |
european country | 8 |
widespread use | 8 |
upper respiratory | 8 |
recent study | 8 |
analysis revealed | 8 |
data show | 8 |
military power | 8 |
bat lyssaviruses | 8 |
leading cause | 8 |
significant public | 8 |
cohort studies | 8 |
soft tissues | 8 |
immunoglobulin products | 8 |
conditions among | 8 |
new areas | 8 |
risk distribution | 8 |
major outbreak | 8 |
health agencies | 8 |
systematic literature | 8 |
take advantage | 8 |
regulatory pressure | 8 |
acute pancreatitis | 8 |
different approaches | 8 |
candida infections | 8 |
sibirica mongolitimonae | 8 |
outbreaks following | 8 |
pulmonary hypertension | 8 |
large numbers | 8 |
imaging data | 8 |
antonine plague | 8 |
animal models | 8 |
randomised controlled | 8 |
climatic conditions | 8 |
brain tissue | 8 |
antigenically related | 8 |
endothelial cells | 8 |
radiological findings | 8 |
mainly due | 8 |
immunodeficiency virus | 8 |
fatal outcome | 8 |
needle biopsy | 8 |
southwestern europe | 8 |
easy access | 8 |
significant risk | 8 |
high costs | 8 |
quarantine measures | 8 |
blood cultures | 8 |
study showed | 8 |
grand challenges | 8 |
related viruses | 8 |
posted june | 8 |
late th | 8 |
health problem | 8 |
different stages | 8 |
past years | 8 |
tourism industry | 8 |
sequence data | 8 |
partial closure | 8 |
infect dis | 8 |
microbiology laboratories | 8 |
rhipicephalus sanguineus | 8 |
available online | 8 |
western countries | 8 |
closed occupations | 8 |
respiratory failure | 8 |
early phase | 8 |
rna segment | 8 |
routine clinical | 8 |
highest level | 8 |
american mink | 8 |
urban areas | 8 |
diseases caused | 8 |
borne flaviviruses | 8 |
infection caused | 8 |
may contribute | 8 |
regional office | 8 |
mosquito species | 8 |
historical data | 8 |
swine flu | 8 |
resistance gene | 8 |
viable tumour | 8 |
two major | 8 |
neutralization testing | 8 |
preventive care | 8 |
pathogenic influenza | 8 |
key findings | 8 |
valvular heart | 8 |
clone i | 8 |
hs hs | 8 |
mouth disease | 8 |
genome comparison | 8 |
future developments | 8 |
environmental conditions | 8 |
found among | 8 |
neurological symptoms | 8 |
chronic granulomatous | 8 |
diabetes mellitus | 8 |
lymphocytic choriomeningitis | 8 |
lyssavirus type | 8 |
will make | 8 |
exposure prophylaxis | 8 |
will become | 8 |
imported case | 8 |
western blot | 8 |
government spending | 8 |
system will | 8 |
recist criteria | 8 |
headcount poverty | 8 |
hantavirus infection | 8 |
vary depending | 8 |
open access | 8 |
factors may | 8 |
domestic cat | 8 |
hiv patients | 8 |
human immunodeficiency | 8 |
dengue hemorrhagic | 8 |
pulmonary disease | 8 |
two decades | 8 |
three distinct | 8 |
marine air | 8 |
candida spp | 8 |
cell carcinoma | 8 |
universal access | 8 |
job security | 8 |
imaging criteria | 8 |
host country | 8 |
right ventricular | 8 |
infected ticks | 8 |
related deaths | 8 |
systematic approach | 8 |
patients may | 8 |
two factors | 8 |
antigenic group | 8 |
climate zone | 8 |
case data | 8 |
clinical management | 8 |
roma men | 8 |
potential impact | 8 |
streptococcus pneumoniae | 8 |
ixodid ticks | 8 |
evidence base | 8 |
dengue viruses | 8 |
ml min | 8 |
tyuleniy island | 8 |
avian viruses | 8 |
become part | 8 |
overall mortality | 8 |
brain tumour | 8 |
managed care | 8 |
molecular dating | 8 |
encephalitis viruses | 8 |
less often | 8 |
black sea | 8 |
relevant information | 8 |
cell culture | 8 |
diagnostic approach | 8 |
epidemiological situation | 8 |
natural gas | 8 |
serological studies | 8 |
new flu | 8 |
personal health | 8 |
matrix protein | 8 |
arterial spin | 8 |
course will | 8 |
cranial nerves | 8 |
therapeutic agents | 8 |
respiratory distress | 8 |
disease activity | 8 |
many parts | 8 |
abdominal pain | 8 |
cancer will | 8 |
vital role | 8 |
see also | 8 |
first cases | 8 |
small organisations | 8 |
viral disease | 8 |
disease process | 8 |
working group | 8 |
body lice | 8 |
etiological agent | 8 |
toe framework | 8 |
congo haemorrhagic | 8 |
end point | 8 |
israeli spotted | 8 |
endemic regions | 8 |
transmitted diseases | 8 |
institutional characteristics | 8 |
global scale | 8 |
free survival | 8 |
universal health | 8 |
nursing homes | 8 |
cases patient | 8 |
clinical routine | 8 |
social sciences | 8 |
flower production | 8 |
west african | 8 |
western european | 8 |
cns disease | 8 |
saharan african | 8 |
appropriate treatment | 8 |
nuclear imaging | 8 |
borne infections | 8 |
current account | 8 |
disease risk | 8 |
social medicine | 8 |
health infrastructure | 8 |
working hours | 8 |
also cause | 8 |
successful ordering | 8 |
online survey | 8 |
key features | 8 |
death rates | 8 |
aged years | 8 |
nonstructural proteins | 8 |
every year | 8 |
disease will | 8 |
health threat | 8 |
among migrants | 8 |
home ranges | 8 |
network analysis | 8 |
chest pain | 8 |
sinv strains | 8 |
even higher | 8 |
cowpox virus | 8 |
virus evolution | 8 |
gastrointestinal symptoms | 8 |
destination southwest | 8 |
population dynamics | 8 |
pulmonary artery | 8 |
transovarial transmission | 8 |
autochthonous cases | 8 |
high genetic | 8 |
global public | 8 |
study design | 8 |
native fauna | 8 |
canary islands | 8 |
diabetic foot | 8 |
reproduction number | 8 |
liver tumours | 8 |
technological change | 8 |
household capital | 8 |
findings will | 8 |
one week | 8 |
different models | 8 |
patients infected | 8 |
vocal cord | 8 |
local authorities | 8 |
national government | 8 |
herpestes ichneumon | 8 |
countries including | 8 |
lesions may | 8 |
high sensitivity | 8 |
ct scan | 8 |
rights reserved | 8 |
nauki i | 8 |
virus genome | 8 |
may play | 8 |
rapid population | 8 |
success rate | 8 |
weather events | 8 |
normal variants | 8 |
mosquito vectors | 8 |
take part | 8 |
ordering role | 8 |
international airport | 8 |
life expectancy | 8 |
surgical procedures | 8 |
poverty index | 8 |
tract infections | 8 |
gata deficiency | 8 |
tissue infections | 8 |
common pitfalls | 8 |
batai virus | 8 |
current state | 8 |
alien species | 8 |
spinal cord | 8 |
jakob disease | 8 |
southern countries | 8 |
coronary heart | 8 |
antiviral therapy | 8 |
puerto rico | 8 |
immune responses | 8 |
among european | 8 |
bartonella henselae | 8 |
pestis genomes | 7 |
active surveillance | 7 |
challenges associated | 7 |
often used | 7 |
mass production | 7 |
ct studies | 7 |
disease processes | 7 |
health programs | 7 |
card deficiency | 7 |
small airport | 7 |
hybrid imaging | 7 |
common ancestor | 7 |
disease caused | 7 |
healthcare systems | 7 |
median age | 7 |
controlled trial | 7 |
drug development | 7 |
geopolitical developments | 7 |
fever group | 7 |
borne rickettsioses | 7 |
borne pathogens | 7 |
eastern asia | 7 |
clinical outcome | 7 |
new diagnostic | 7 |
irregular migrants | 7 |
key factors | 7 |
zoonotic transmission | 7 |
based medicine | 7 |
showed high | 7 |
logistical challenges | 7 |
techniques used | 7 |
southern hemisphere | 7 |
practice guidelines | 7 |
airport operator | 7 |
also called | 7 |
treatment strategies | 7 |
capital stock | 7 |
different ways | 7 |
prevent transmission | 7 |
among patients | 7 |
lesions will | 7 |
important factors | 7 |
three different | 7 |
cases may | 7 |
patients presenting | 7 |
bank voles | 7 |
disease may | 7 |
waste management | 7 |
epidemic potential | 7 |
southern russia | 7 |
organ failure | 7 |
cell wall | 7 |
also includes | 7 |
sand flies | 7 |
unemployment rate | 7 |
relative risk | 7 |
image interpretation | 7 |
mrsa prevalence | 7 |
past decade | 7 |
visceral leishmaniasis | 7 |
renal function | 7 |
european community | 7 |
myocardial perfusion | 7 |
holland america | 7 |
great gerbil | 7 |
waterborne disease | 7 |
far eastern | 7 |
european host | 7 |
working ability | 7 |
respiratory infections | 7 |
mean age | 7 |
migrant effect | 7 |
panel discussion | 7 |
valentine leukocidin | 7 |
solid tumours | 7 |
comparative studies | 7 |
bunyamwera group | 7 |
clinical setting | 7 |
spatial pattern | 7 |
sectional study | 7 |
older age | 7 |
pneumococcal pneumonia | 7 |
serious threat | 7 |
california serogroup | 7 |
prevalence studies | 7 |
ussr academy | 7 |
might also | 7 |
mediterranean sea | 7 |
molecular typing | 7 |
larger airports | 7 |
iberian peninsula | 7 |
will depend | 7 |
care institutions | 7 |
chronic infections | 7 |
old world | 7 |
high rates | 7 |
group includes | 7 |
argasid ticks | 7 |
low sensitivity | 7 |
patients present | 7 |
gave rise | 7 |
new variant | 7 |
clinical course | 7 |
health information | 7 |
preventable diseases | 7 |
patient safety | 7 |
rapid spread | 7 |
population displacement | 7 |
rvp assay | 7 |
may become | 7 |
child health | 7 |
messenger rnas | 7 |
human morbidity | 7 |
like illness | 7 |
outer membrane | 7 |
comprehensive approach | 7 |
dates back | 7 |
appropriate imaging | 7 |
genetic lineage | 7 |
successfully treated | 7 |
correct diagnosis | 7 |
health intervention | 7 |
results suggest | 7 |
use oil | 7 |
cell line | 7 |
using different | 7 |
knowledge base | 7 |
death model | 7 |
roman empire | 7 |
free market | 7 |
consumer pressure | 7 |
rattus norvegicus | 7 |
academic institutions | 7 |
carbapenem resistance | 7 |
two scenarios | 7 |
contaminated water | 7 |
detected among | 7 |
viral rna | 7 |
may develop | 7 |
genomic rna | 7 |
arthroplasty surgeons | 7 |
robert koch | 7 |
migratory flows | 7 |
new approach | 7 |
imaging technologies | 7 |
without clinical | 7 |
foreign policy | 7 |
high frequency | 7 |
question whether | 7 |
rather low | 7 |
chlamydia trachomatis | 7 |
many factors | 7 |
may show | 7 |
observational studies | 7 |
factors including | 7 |
resistant staphylococcus | 7 |
molecular genetic | 7 |
case series | 7 |
critical role | 7 |
environmental target | 7 |
antibiotic susceptibility | 7 |
specific antibody | 7 |
healthy migrant | 7 |
health outcomes | 7 |
trade agreements | 7 |
fiscal deficit | 7 |
european trials | 7 |
climate variability | 7 |
information regarding | 7 |
first half | 7 |
hospital stay | 7 |
specific disease | 7 |
naegleria fowleri | 7 |
market share | 7 |
response rates | 7 |
adult population | 7 |
management practices | 7 |
asiaticum ticks | 7 |
phlebovirus genus | 7 |
deaths due | 7 |
phylogenetic analyses | 7 |
hubei province | 7 |
framework program | 7 |
health surveillance | 7 |
review will | 7 |
helicobacter pylori | 7 |
migration rate | 7 |
health doi | 7 |
five years | 7 |
positive specimens | 7 |
tertiary prevention | 7 |
cruise line | 7 |
sample taker | 7 |
real interest | 7 |
social determinants | 7 |
enzyme immunoassay | 7 |
specific infections | 7 |
common practice | 7 |
inflammatory responses | 7 |
confidence intervals | 7 |
daily practice | 7 |
health action | 7 |
aspergillus fumigatus | 7 |
gini coefficient | 7 |
differences across | 7 |
population size | 7 |
human remains | 7 |
immune deficiency | 7 |
tropical zone | 7 |
percutaneous ablation | 7 |
sustainability transitions | 7 |
signal intensity | 7 |
genomic analysis | 7 |
louping ill | 7 |
ticks ornithodoros | 7 |
congenital heart | 7 |
nephropathia epidemica | 7 |
membrane protein | 7 |
distinct species | 7 |
potential role | 7 |
health organisation | 7 |
haemaphysalis longicornis | 7 |
environmental performance | 7 |
badger setts | 7 |
physical examination | 7 |
taking place | 7 |
highly virulent | 7 |
first international | 7 |
also provides | 7 |
royal caribbean | 7 |
receptor specificity | 7 |
cut flowers | 7 |
hcv infection | 7 |
eastern european | 7 |
adipose tissue | 7 |
european continent | 7 |
aviation supply | 7 |
oncologic patients | 7 |
gdp growth | 7 |
highest number | 7 |
air quality | 7 |
three groups | 7 |
close contact | 7 |
fiscal consolidation | 7 |
environmental changes | 7 |
patients will | 7 |
last three | 7 |
bowel disease | 7 |
molecular diagnostics | 7 |
table shows | 7 |
new insights | 7 |
posterior support | 7 |
coronavirus infection | 7 |
infection may | 7 |
relatively small | 7 |
treatment failure | 7 |
legal powers | 7 |
one study | 7 |
also shown | 7 |
tumour progression | 7 |
also affected | 7 |
cranial nerve | 7 |
ticks argas | 7 |
associated infections | 7 |
civil contingencies | 7 |
benign lesions | 7 |
transmission tree | 7 |
health perspective | 7 |
syndrome virus | 7 |
mr spectroscopy | 7 |
additional imaging | 7 |
european economic | 7 |
uria aalge | 7 |
global level | 7 |
time points | 7 |
trade balance | 7 |
virus closely | 7 |
clinical disease | 7 |
deep transitions | 7 |
type diabetes | 7 |
marburg virus | 7 |
significant difference | 7 |
another important | 7 |
commons licence | 7 |
private sector | 7 |
phylogenetic relationships | 7 |
three decades | 7 |
test results | 7 |
atpase gene | 7 |
aa identities | 7 |
york city | 7 |
first week | 7 |
health data | 7 |
european society | 7 |
health risks | 7 |
bat origin | 7 |
bird species | 7 |
directly related | 7 |
family members | 7 |
broad spectrum | 7 |
specific diseases | 7 |
ct may | 7 |
body fluids | 7 |
multiple sclerosis | 7 |
rickettsia helvetica | 7 |
severe covid | 7 |
facial nerve | 7 |
refresher course | 7 |
like disease | 7 |
metastatic disease | 7 |
epithelial cells | 7 |
epidemiological characteristics | 7 |
genus flavivirus | 7 |
omsk haemorrhagic | 7 |
world politics | 7 |
last decades | 7 |
interest payments | 7 |
imaging probes | 7 |
child protection | 7 |
innate immune | 7 |
will include | 7 |
several cases | 7 |
chronic hepatitis | 7 |
brain imaging | 7 |
high quality | 7 |
cranial fossa | 7 |
institutional settings | 7 |
acute aortic | 7 |
high spatial | 7 |
puumala hantavirus | 7 |
century ce | 7 |
semiaquatic birds | 7 |
patients suffering | 7 |
health impacts | 7 |
basic principles | 7 |
whole population | 7 |
increased number | 7 |
fiscal policy | 7 |
visa isolates | 7 |
infected animals | 7 |
lepus europaeus | 7 |
international relations | 7 |
pcr ribotype | 7 |
patients receiving | 7 |
political economy | 7 |
meteorological conditions | 7 |
single orf | 7 |
different purposes | 7 |
range size | 7 |
health legislation | 7 |
greenhouse gas | 7 |
sibirica subsp | 7 |
aedes vexans | 7 |
ticks hyalomma | 6 |
various parts | 6 |
specific health | 6 |
chest wall | 6 |
intravenous immunoglobulin | 6 |
serologic testing | 6 |
examination may | 6 |
serological data | 6 |
obligate parasites | 6 |
figures refer | 6 |
predominant tick | 6 |
natural focus | 6 |
specific igm | 6 |
breast lesions | 6 |
external border | 6 |
therapeutic options | 6 |
oil supply | 6 |
central africa | 6 |
immunodeficiency disorders | 6 |
usutu virus | 6 |
country risk | 6 |
patients required | 6 |
azole antifungals | 6 |
wnv circulation | 6 |
bacterial strains | 6 |
immunofluorescence assay | 6 |
vaccinia virus | 6 |
probably due | 6 |
three months | 6 |
clinical cases | 6 |
human behavior | 6 |
treatment option | 6 |
may reflect | 6 |
asset markets | 6 |
mri examination | 6 |
borne lymphadenopathy | 6 |
diagnostic testing | 6 |
antifungal therapy | 6 |
health equity | 6 |
great plague | 6 |
natural resources | 6 |
enhanced mr | 6 |
vessel wall | 6 |
longicornis ticks | 6 |
commercially available | 6 |
ns gene | 6 |
also used | 6 |
ct images | 6 |
oecd countries | 6 |
clinical forms | 6 |
various forms | 6 |
side effects | 6 |
prototype strain | 6 |
help us | 6 |
relative humidity | 6 |
negative predictive | 6 |
soviet republic | 6 |
tobacco smoke | 6 |
rapid development | 6 |
invasive fungal | 6 |
twenty years | 6 |
simultaneous detection | 6 |
several factors | 6 |
adjuvant chemotherapy | 6 |
roma population | 6 |
climatic changes | 6 |
millennium development | 6 |
dogs nyctereutes | 6 |
new guinea | 6 |
paediatric tuberculosis | 6 |
rodent species | 6 |
converting enzyme | 6 |
image reconstruction | 6 |
lyme borreliosis | 6 |
microgram ml | 6 |
vibrio cholerae | 6 |
blood stream | 6 |
larus argentatus | 6 |
bloodsucking mosquitoes | 6 |
common ground | 6 |
demographic transition | 6 |
heart diseases | 6 |
brachial plexus | 6 |
rna virus | 6 |
hiv prevention | 6 |
new techniques | 6 |
within days | 6 |
service providers | 6 |
specific diagnosis | 6 |
among different | 6 |
antifungal agents | 6 |
th centuries | 6 |
geographic region | 6 |
focal point | 6 |
catalytic core | 6 |
clinical evaluation | 6 |
next years | 6 |
athenian plague | 6 |
clinical manifestation | 6 |
hemagglutination inhibition | 6 |
less important | 6 |
virulence genes | 6 |
phage therapy | 6 |
antigenic complex | 6 |
bank vole | 6 |
war effort | 6 |
serum samples | 6 |
local health | 6 |
cases will | 6 |
diagnostic tool | 6 |
higher level | 6 |
rna genome | 6 |
studies showed | 6 |
special emphasis | 6 |
european fauna | 6 |
cv risk | 6 |
mediterranean region | 6 |
increased mortality | 6 |
sars outbreak | 6 |
suckling pigs | 6 |
nairovirus reflects | 6 |
indian subcontinent | 6 |
cholera cases | 6 |
lung parenchyma | 6 |
reuse allowed | 6 |
cigarette smoking | 6 |
first line | 6 |
coming years | 6 |
virological monitoring | 6 |
issues related | 6 |
common conditions | 6 |
fruit bats | 6 |
london uk | 6 |
calculated based | 6 |
landscape belt | 6 |
clinical cure | 6 |
flood affected | 6 |
infecting humans | 6 |
obtained using | 6 |
human sera | 6 |
fatty liver | 6 |
migration rates | 6 |
diagnostic criteria | 6 |
viral replication | 6 |
experimental study | 6 |
closed activities | 6 |
confirmed covid | 6 |
human pathogen | 6 |
tick hosts | 6 |
vary widely | 6 |
health legal | 6 |
great gerbils | 6 |
risks associated | 6 |
information systems | 6 |
new representative | 6 |
current knowledge | 6 |
current pandemic | 6 |
financial support | 6 |
internal market | 6 |
welfare state | 6 |
restriction analysis | 6 |
drug efflux | 6 |
index case | 6 |
hemophagocytic lymphohistiocytosis | 6 |
iterative reconstruction | 6 |
major role | 6 |
cruise lines | 6 |
without compromising | 6 |
global perspective | 6 |
type i | 6 |
talk will | 6 |
allowed without | 6 |
growing concern | 6 |
physical distancing | 6 |
existing literature | 6 |
sanitary conventions | 6 |
vascular access | 6 |
high resolution | 6 |
clinical isolate | 6 |
skin biopsies | 6 |
canine distemper | 6 |
benign tumours | 6 |
preventing disease | 6 |
first isolation | 6 |
will illustrate | 6 |
medical practice | 6 |
epidemic outbreak | 6 |
distress syndrome | 6 |
one year | 6 |
newly arrived | 6 |
isolated cases | 6 |
image wisely | 6 |
internal parts | 6 |
pig mortality | 6 |
mechanically ventilated | 6 |
first year | 6 |
imaging examinations | 6 |
domestic cats | 6 |
virus encephalitis | 6 |
emerging disease | 6 |
respiratory symptoms | 6 |
cruise industry | 6 |
human settlements | 6 |
new problems | 6 |
work together | 6 |
murine typhus | 6 |
imaging procedures | 6 |
multimodality imaging | 6 |
young roma | 6 |
rickettsia rickettsii | 6 |
typhoid fever | 6 |
recent data | 6 |
macrolide resistance | 6 |
recycling waste | 6 |
virus strain | 6 |
geographical movement | 6 |
related infections | 6 |
pseudomonas aeruginosa | 6 |
global value | 6 |
selective pressure | 6 |
obligate intracellular | 6 |
similar results | 6 |
realtime detection | 6 |
restricted diffusion | 6 |
cases occurred | 6 |
aircraft noise | 6 |
cell transplant | 6 |
differential diagnoses | 6 |
major risk | 6 |
transmissible gastroenteritis | 6 |
supplementary material | 6 |
human rabies | 6 |
trade barriers | 6 |
virus type | 6 |
adriatic islands | 6 |
may allow | 6 |
roma communities | 6 |
healthy public | 6 |
inflammatory lesions | 6 |
fourth surge | 6 |
uspekhi nauki | 6 |
trench fever | 6 |
i tekhniki | 6 |
new developments | 6 |
enveloped viruses | 6 |
pulmonary arterial | 6 |
pallidum subsp | 6 |
adversely affect | 6 |
health policies | 6 |
staff members | 6 |
environmental regulation | 6 |
lymphocyte apoptosis | 6 |
one another | 6 |
cent vs | 6 |
make use | 6 |
adult patients | 6 |
deposition certificate | 6 |
semliki forest | 6 |
third party | 6 |
less frequently | 6 |
urgent need | 6 |
breast us | 6 |
blood supply | 6 |
culex tritaeniorhynchus | 6 |
management systems | 6 |
several european | 6 |
like virus | 6 |
decreased susceptibility | 6 |
bat virus | 6 |
early spread | 6 |
tyuleniy virus | 6 |
among young | 6 |
lower level | 6 |
small carnivores | 6 |
individual patients | 6 |
discussion will | 6 |
patient outcome | 6 |
may require | 6 |
tissue sampling | 6 |
inequality component | 6 |
public opinion | 6 |
volgograd region | 6 |
ethnic racial | 6 |
tissue contrast | 6 |
clinical decision | 6 |
carbon monoxide | 6 |
prevalence among | 6 |
icu support | 6 |
across regions | 6 |
severe infections | 6 |
specific treatment | 6 |
world population | 6 |
rural areas | 6 |
tick species | 6 |
especially among | 6 |
highly contagious | 6 |
equine encephalitis | 6 |
environmental degradation | 6 |
large cities | 6 |
eastern germany | 6 |
wild rodents | 6 |
antibody titers | 6 |
air temperature | 6 |
pulmonary embolism | 6 |
observed differences | 6 |
us contrast | 6 |
health hazards | 6 |
diagnostic radiology | 6 |
partial sequences | 6 |
new technology | 6 |
human pathogens | 6 |
environmental policy | 6 |
antiretroviral therapy | 6 |
virus among | 6 |
data indicate | 6 |
chronic conditions | 6 |
global trends | 6 |
significant number | 6 |
phlebotomus fever | 6 |
national surveillance | 6 |
natural focies | 6 |
efficient use | 6 |
may mimic | 6 |
ancient microbial | 6 |
fields virology | 6 |
clinical presentations | 6 |
deleterious impact | 6 |
host species | 6 |
patients received | 6 |
countries outside | 6 |
associated pneumonia | 6 |
origin countries | 6 |
also seen | 6 |
cerebrovascular disease | 6 |
mixed forests | 6 |
joint arthroplasty | 6 |
mri techniques | 6 |
public baths | 6 |
serological survey | 6 |
otitis media | 6 |
contingencies act | 6 |
legal systems | 6 |
dating analysis | 6 |
severe cases | 6 |
produced immunoglobulin | 6 |
plain radiography | 6 |
eastern caribbean | 6 |
several major | 6 |
health crisis | 6 |
new epicentres | 6 |
clinical aspects | 6 |
shell vial | 6 |
industrialised countries | 6 |
collection systems | 6 |
indicate trade | 6 |
fdg pet | 6 |
infections occur | 6 |
tumour biology | 6 |
cardiac mr | 6 |
modern public | 6 |
victorian era | 6 |
different institutional | 6 |
original us | 6 |
take care | 6 |
southern parts | 6 |
also common | 6 |
clinical guidelines | 6 |
tumour tissue | 6 |
candida auris | 6 |
clinical relevance | 6 |
resource management | 6 |
various countries | 6 |
personal hygiene | 6 |
asiaticum asiaticum | 6 |
day mortality | 6 |
rna segments | 6 |
like receptors | 6 |
seven patients | 6 |
health planning | 6 |
increasing number | 6 |
resistant tuberculosis | 6 |
income inequality | 6 |
health facilities | 6 |
gas emissions | 6 |
utility function | 6 |
several hundred | 6 |
bloodstream infections | 6 |
anas acuta | 6 |
images will | 6 |
common variable | 6 |
will show | 6 |
intravenous drug | 6 |
middle eastern | 6 |
wide distribution | 6 |
tensor imaging | 6 |
low level | 6 |
data analysis | 6 |
sized carnivores | 6 |
human health | 6 |
potential pitfalls | 6 |
useful tool | 6 |
ongoing covid | 6 |
ablation zone | 6 |
apparent diffusion | 6 |
antimicrobial agents | 6 |
high rate | 6 |
diffusion tensor | 6 |
clinical outcomes | 6 |
advanced mr | 6 |
ill patients | 6 |
sample takers | 6 |
antifungal treatment | 6 |
changing world | 6 |
disseminated disease | 6 |
outbreak occurred | 6 |
high cost | 6 |
communication technologies | 6 |
much less | 6 |
air services | 6 |
kul fever | 6 |
severe form | 6 |
ukrainian soviet | 6 |
diffusion weighted | 6 |
prospective study | 6 |
interpretive analysis | 6 |
powers act | 6 |
neuroinvasive disease | 6 |
sakhalin island | 6 |
type birth | 6 |
infect humans | 6 |
external borders | 6 |
fat content | 6 |
movement across | 6 |
antiviral drugs | 6 |
potential benefits | 6 |
rocky mountain | 6 |
inflammatory diseases | 6 |
evidence suggests | 6 |
million cases | 6 |
framework programme | 6 |
northern european | 6 |
also reported | 6 |
diagnostic value | 6 |
peripheral blood | 6 |
clinical characteristics | 6 |
schot kanger | 6 |
iv thrombolysis | 6 |
immune layer | 6 |
may reduce | 6 |
north macedonia | 6 |
countries around | 6 |
microbiology laboratory | 6 |
mongoose herpestes | 6 |
beliefs related | 6 |
multidetector ct | 6 |
nonpharmaceutical interventions | 6 |
acanthamoeba spp | 6 |
may increase | 6 |
may involve | 6 |
member state | 6 |
chim virus | 6 |
paradigm shift | 6 |
influenza outbreaks | 6 |
viral genome | 6 |
epidemiological data | 6 |
highly fatal | 6 |
small european | 6 |
intertemporal general | 6 |
health workers | 6 |
distinct branch | 6 |
surgical resection | 6 |
see chapters | 6 |
neutralization tests | 6 |
pathogen screening | 6 |
first scenario | 6 |
financial flows | 6 |
international air | 6 |
much lower | 6 |
like cov | 6 |
trade networks | 6 |
social conditions | 6 |
risk stratification | 6 |
rate among | 6 |
immunodeficient patients | 6 |
continental europe | 6 |
negative polarity | 6 |
published studies | 6 |
risk areas | 6 |
caribbean islands | 6 |
pancreatic cystic | 6 |
atlantic oscillation | 6 |
recurrence rate | 6 |
countries indicate | 6 |
low cost | 6 |
frontier research | 6 |
dublin regulation | 6 |
incidence rate | 6 |
ancient human | 6 |
mountain spotted | 6 |
health impact | 6 |
structural changes | 6 |
susceptible population | 6 |
significant role | 6 |
socioeconomic status | 6 |
diffusion coefficient | 6 |
south asia | 6 |
last two | 6 |
body temperature | 6 |
tetracycline resistance | 6 |
resistance among | 6 |
periprosthetic fractures | 6 |
acute infection | 6 |
monoclonal antibody | 6 |
large vessel | 6 |
perfusion techniques | 6 |
professional standards | 6 |
roma living | 6 |
medical profession | 6 |
imaging evaluation | 6 |
diseases may | 6 |
overall prevalence | 6 |
foci virus | 6 |
mutation frequency | 6 |
one country | 6 |
food safety | 6 |
inkoo virus | 6 |
war era | 6 |
jugular foramen | 6 |
positive isolates | 6 |
right heart | 6 |
mild disease | 6 |
meningococcal disease | 6 |
virus outbreak | 6 |
primary end | 6 |
abdominal organs | 6 |
herd immunity | 6 |
oncology patients | 6 |
first three | 6 |
small number | 6 |
disease patterns | 6 |
antimicrobial susceptibility | 6 |
right column | 6 |
allow us | 6 |
primary bone | 6 |
left column | 6 |
litter size | 6 |
direct detection | 6 |
floriculture supply | 6 |
different strains | 6 |
northern hemisphere | 6 |
flower farms | 6 |